• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

BNP Paribas Developpement buys stake in Unipex

  • Francesca Veronesi
  • Francesca Veronesi
  • 22 October 2019
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

BNP Paribas Developpement has acquired a minority stake in Unipex, a French speciality chemicals business.

A source familiar with the situation confirmed that founders of the business have retained a substantial majority in the company, while the management has acquired a small minority.

The GP invested €8.8m in the company; the deal values the business at €56m, according to French publication Capital Finance. The report also claimed that the three owners plan to sell the business to a private equity firm in three to five years.

Unipex

  • DEAL:

    MBO

  • VALUE:

    n/d (€56m est)

  • LOCATION:

    Paris

  • SECTOR:

    Speciality chemicals

  • FOUNDED:

    1968

  • TURNOVER:

    n/d (€92m est)

Senior debt for the transaction was provided by Societe Generale, CIC and BNP Paribas.

Previous funding
IK Investment Partners acquired a majority stake in French speciality chemicals business Unipex Group from Ardian in 2012. The new owner invested via its IK 2007 fund, which closed on €1.675bn in 2007. Debt financing was provided by Ares and LFPI. 

The business generated revenues of €200m in 2012, Unquote previously reported. The following year, Unipex refinanced its debt with a new €121m package, in the form of a senior loan, mezzanine funding and acquisition facilities. Bank of Ireland Group, Credit Industriel et Commercial, GE Capital Corporation and KBC Groep NV acted as senior lead arrangers, with the mezzanine tranche being underwritten by LFPI, Ares Management and European Capital.

The GP sold Unipex subsidiary Lucas Meyer Cosmetics, a Canadian flavour and fragrance manufacturer, to International Flavors & Fragrances for €283m in June 2015, before exiting its stake in the business via management buy-back in September that year. The transaction was financed by European Capital, which invested €25m in unitranche.

Company
Founded in 1968, Unipex specialises in the development, production, marketing and distribution of active ingredients, speciality chemicals and other chemical products. It specifically targets the cosmetics, pharmaceutical, nutrition and industrial sectors.

The Paris-based group has offices in Belgium and Morocco. The company recorded a €92m turnover in 2018, according to Capital Finance.

People
BNP Paribas développement – Frederique Cassignol (investment director). 
Unipex – Patrice Barthelmes (CEO).

Advisers
Company
– Willkie Farr & Gallagher (legal).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • France
  • Industrials
  • France

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013